1 MONTELUKAST SODIUM | 10 of 40 | 2300 prescriptions Less than 1% of all prescriptions | 1860 | 780 patients 35% of all patients | 620 patients 28% of all patients | |
2 BREO ELLIPTA (FLUTICASONE/VILANTEROL) | 10 of 30 | 1080 prescriptions Less than 1% of all prescriptions | | 320 patients 14% of all patients | < 11 | |
3 FLUTICASONE PROPIONATE | 10 of 60 | 1060 prescriptions Less than 1% of all prescriptions | 910 | 530 patients 24% of all patients | 420 patients 19% of all patients | |
4 SPIRIVA RESPIMAT (TIOTROPIUM BROMIDE) | 10 | 580 prescriptions Less than 1% of all prescriptions | 400 | 210 patients 9% of all patients | < 11 | |
5 SYMBICORT (BUDESONIDE/FORMOTEROL FUMARATE) | 10 of 40 | 710 prescriptions Less than 1% of all prescriptions | 470 | 270 patients 12% of all patients | < 11 | |
6 INCRUSE ELLIPTA (UMECLIDINIUM BROMIDE) | 10 | 660 prescriptions Less than 1% of all prescriptions | 660 | 150 patients 7% of all patients | 150 patients 7% of all patients | |
7 PROAIR HFA (ALBUTEROL SULFATE) | 20 of 30 | 350 prescriptions Less than 1% of all prescriptions | | 240 patients 11% of all patients | < 11 | |
8 ANORO ELLIPTA (UMECLIDINIUM BRM/VILANTEROL TR) | 10 of 20 | 430 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
9 ADVAIR DISKUS (FLUTICASONE PROPION/SALMETEROL) | 20 of 20 | 250 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
10 PREDNISONE | 20 of 30 | 550 prescriptions Less than 1% of all prescriptions | | 340 patients 15% of all patients | < 11 | |
11 VENTOLIN HFA (ALBUTEROL SULFATE) | 20 of 50 | 340 prescriptions Less than 1% of all prescriptions | | 190 patients 8% of all patients | < 11 | |
12 ADCIRCA (TADALAFIL) | 20 of 20 | 280 prescriptions Less than 1% of all prescriptions | 280 | < 11 | < 11 | |
13 TRELEGY ELLIPTA (FLUTICASONE/UMECLIDIN/VILANTER) | 10 | 200 prescriptions Less than 1% of all prescriptions | | 110 patients 5% of all patients | < 11 | |
14 AZITHROMYCIN | 10 of 30 | 260 prescriptions Less than 1% of all prescriptions | | 150 patients 7% of all patients | < 11 | A |
15 SPIRIVA (TIOTROPIUM BROMIDE) | 10 of 20 | 140 prescriptions Less than 1% of all prescriptions | | 110 patients 5% of all patients | < 11 | |
16 ORENITRAM ER (TREPROSTINIL DIOLAMINE) | 10 | 190 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
17 ARNUITY ELLIPTA (FLUTICASONE FUROATE) | 10 | 120 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
18 MOMETASONE FUROATE | 10 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
19 LETAIRIS (AMBRISENTAN) | 20 of 20 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
20 TADALAFIL | 10 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
21 DEXTROAMPHETAMINE-AMPHETAMINE (DEXTROAMPHETAMINE/AMPHETAMINE) | 20 of 30 | 110 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
22 DALIRESP (ROFLUMILAST) | 10 of 20 | 110 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |
23 METHYLPREDNISOLONE | 10 of 20 | 310 prescriptions Less than 1% of all prescriptions | | 240 patients 11% of all patients | < 11 | |
24 DOXYCYCLINE HYCLATE | 20 of 20 | 130 prescriptions Less than 1% of all prescriptions | | 130 patients 6% of all patients | < 11 | A |